Company profile
ノイルイミューン・バイオテック株式会社
Industry position
Pharmaceutical
Latest half-year results
H1 FY2026
Operating income was -¥419.98 million, down 1.8% year over year. Net income was -¥372.02 million, up 9.6% year over year.
Half-year trend
Half-year financial trend
H1 values are cumulative year-to-date.
H2 values are calculated when comparable.
Standalone · Japanese GAAP · Cumulative YTD
Half-year financial data
Annual key financial indicators
FY2025
Operating income was -¥797.26 million, up 25.4% year over year. Net income was -¥793.54 million, up 17.7% year over year. ROE was -20.2%; equity ratio was 97.8%; free cash flow was -¥752.6 million.
Industry position details
Pharmaceutical
Annual data for the same fiscal year and industry
FY2025 Comparison sample 32
ROE Top 35%
Equity ratio Top 4%
Annual financial data
| Fiscal year | Scope | Accounting standard | Revenue | Operating income | Ordinary income | Profit before tax | Net income | Profit attributable to owners of parent | Comprehensive income | Total assets | Total liabilities | Net assets | Shareholders' equity | Equity | Equity attributable to owners of parent | Equity for ratio | Operating cash flow | Investing cash flow | Financing cash flow | Free cash flow | Cash and cash equivalents | Basic EPS | P/E | Share price | Market cap | Book value per share | Dividend per share | Shares issued | Equity ratio | Official equity ratio | ROE | ROA | Operating margin | Ordinary income margin | Net margin | Operating cash flow margin | Free cash flow margin | Dividend payout ratio | Revenue YoY | Operating income YoY | Ordinary income YoY | Profit before tax YoY | Net income YoY | Total assets YoY | Equity YoY | Operating cash flow YoY | Investing cash flow YoY | Financing cash flow YoY | Free cash flow YoY | Cash and cash equivalents YoY | EPS YoY | Dividend per share YoY | Shares issued YoY | Employees YoY | Average salary YoY | Employees | Average salary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Standalone | Japanese GAAP | -797255000 | -791116000 | -793536000 | 4011579000 | 79639000 | 3931939000 | 3925092000 | 3931939000 | -752219000 | -378000 | -20000 | -752597000 | 3918321000 | -18.33 | 90.65 | 43301765 | 0.9801474681 | 0.978 | -0.2018179834 | -0.1978113855 | 0.2543325137 | 0.1776640143 | 0.1772182217 | -0.1642843215 | -0.1679311192 | 0.1527242909 | -1.6786355476 | -1.008 | 0.1517663527 | -0.1611277732 | 0.1772890485 | 0.0 | -0.08 | -0.0306891355 | 23 | 7075000 | |||||||||||||||||||
| FY2024 | Standalone | Japanese GAAP | -1069183000 | -962035000 | -964455000 | 4800172000 | 74675000 | 4725497000 | 4718649000 | 4725497000 | -887809000 | 557000 | 2500000 | -887252000 | 4670939000 | -22.28 | 108.97 | 43301765 | 0.9844432658 | 0.983 | -0.2040959924 | -0.2009209253 | -0.3788952928 | 0.1468250097 | 0.1465105742 | -0.1693689472 | -0.1691363725 | -0.0168748196 | 1.1047780286 | -0.9986932109 | -0.0100866128 | -0.1592514774 | 0.1823853211 | 0.0005776772 | -0.1071428571 | -0.0809619743 | 25 | 7299000 | |||||||||||||||||||
| FY2023 | Standalone | Japanese GAAP | -775391000 | -1127594000 | -1130014000 | 5778946000 | 91494000 | 5687452000 | 5680550000 | 5687452000 | -873076000 | -5316000 | 1913086000 | -878392000 | 5555691000 | -27.25 | 131.26 | 43276765 | 0.9841677012 | 0.983 | -0.198685457 | -0.1955398095 | 28 | 7942000 |
Source filings
Select a document type to load the filings list.
Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp